Lobbying organisation

American Chamber of Commerce in Canada

22 meetings with public office holders, Jun 17, 2025 to Aug 6, 2026.

Meetings over time

  • Jun 2025: 1 meeting, with Drew Leyburne, Matt Jones
  • Jul 2025: 0 meetings
  • Aug 2025: 0 meetings
  • Sep 2025: 0 meetings
  • Oct 2025: 1 meeting, with Dan Lindenas
  • Nov 2025: 0 meetings
  • Dec 2025: 1 meeting, with Mary Rose Brown
  • Jan 2026: 2 meetings, with Jamil Jivani
  • Feb 2026: 0 meetings
  • Mar 2026: 2 meetings, with Ali Ehsassi, Pierre Poilievre, Charles Vincent, Galen Richardson
  • Apr 2026: 3 meetings, with Stephen Fuhr, James Rourke, James Cudmore, Levent Ozmutlu, Mark Wiseman
  • May 2026: 4 meetings, with Wilder Walker-Stewart, Dan Le Bouthillier, Lauren Conway, Mark Wiseman
  • Jun 2026: 6 meetings, with Galen Richardson, Martin Moen, Glen Linder, Joanne Lostracco, Kayla Slobodnik
  • Jul 2026: 1 meeting, with Mark Wiseman
  • Aug 2026: 1 meeting, with Janice Charette
Jun 2025peak 6 in a monthAug 2026

Hover or focus a month to see who was met.

What they lobby about

The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.

Who they met

Liberal2 met · 2 meetings
Not in Arena's member list19 met · 23 meetings
  • Mark Wiseman
  • Lauren Conway
  • Martin Moen
  • Charles Vincent
  • Dan Le Bouthillier
  • Dan Lindenas
  • Drew Leyburne
  • Galen Richardson
  • Galen Richardson
  • Glen Linder
  • James Cudmore
  • James Rourke
  • Janice Charette
  • Joanne Lostracco
  • Kayla Slobodnik
  • Levent Ozmutlu
  • Mary Rose Brown
  • Matt Jones
  • Wilder Walker-Stewart

Global Affairs Canada (GAC) (8) · House of Commons (7) · Public Services and Procurement Canada (PSPC) (6) · Privy Council Office (PCO) (4) · Innovation, Science and Economic Development Canada (ISED) (1) · Treasury Board Of Canada Secretariat (TBS) (1)

In their own words

  • Communications with public office holders regarding policies, regulations and programs affecting pharmaceutical pricing and reimbursement frameworks, including the Patented Medicine Prices Review Board (PMPRB), international reference pricing approaches, most-favoured-nation pricing policies and their impacts on investment, innovation, market access and the availability of medicines and health technologies in Canada.
  • Communications with public office holders regarding the implementation of the Digital Services Tax Act, Online News Act, Online Streaming Act, including as it relates to regulations and conditions applicable to American corporations operating in Canada.
  • Communications with public office holders regarding policies and initiatives to encourage trade between Canada and the United States, including with regard to the United States-Mexico-Canada Agreement (USMCA).

Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.